Biotech and Pharmaceuticals
Shortage of Novo Nordisk’s Wegovy and Ozempic drugs is resolved, FDA says
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters The long-running U.S. shortage of Novo Nordisk‘s blockbuster weight loss injection Wegovy and diabetes treatment Ozempic is resolved after more than two years, the Food and Drug Administration said on Friday. The FDA’s decision will threaten the […]
Read More
Shortage of Novo’s Wegovy and Ozempic is resolved, FDA website shows
Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images A shortage of Danish drugmaker Novo Nordisk’s popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, the U.S. Food and Drug Administration’s website showed on […]
Read More
UnitedHealth’s rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months
FILE PHOTO: The logo of Down Jones Industrial Average stock market index listed company UnitedHealthcare is shown in Cypress, California April 13, 2016. Mike Blake | Reuters UnitedHealthcare is in hot water again as the insurance giant grapples with a reported government investigation of its Medicare billing practices, pursues employee buyouts and potential layoffs and […]
Read More
From pills to new uses, here’s what Eli Lilly’s top scientist sees as the future of weight loss drugs
Dan Skovronsky knows what makes a good obesity drug. As chief scientific officer at Eli Lilly, he’s already done it once with the company’s weekly shot, Zepbound. He’s trying to do it again with a more convenient daily pill, then repeat the feat with a shot that could be even more powerful than Zepbound. And […]
Read More
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Steve Christo | Corbis News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novo Nordisk‘s blockbuster diabetes drug Ozempic may also help people drink less alcohol. That’s according to new government-funded research […]
Read More
UnitedHealthcare is offering buyouts to employees in benefits unit, could pursue layoffs, sources say
A general view outside the United Healthcare corporate headquarters on December 4, 2024 in Minnetonka, Minnesota. Stephen Maturen | Getty Images UnitedHealthcare is offering certain employees in its benefits operations unit the option to accept buyouts if they quit by March 3, following a tumultuous year for the insurance giant, CNBC has learned. Those who […]
Read More
Moderna beats on revenue but loses more than expected as it scales down manufacturing
Moderna on Friday posted fourth-quarter revenue that beat estimates, but lost more than expected for the period, as the biotech company continues to slash costs and demand for its Covid vaccine falls. It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the rapid decline […]
Read More
CVS shares are up 45% this year — here’s why it may be starting to turn its business around
The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada, on Feb. 7, 2024. Patrick T. Fallon | AFP | Getty Images After a dismal 2024, CVS Health could be starting to turn itself around. Some investors seem convinced, especially after the retail drugstore chain on […]
Read More
Healthy Returns: What to know about Trump’s NIH funding cuts
Biotech researchers. Janiecbros | E+ | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The Trump administration is trying to implement major funding cuts to the National Institutes of Health that would cap […]
Read More
CVS CEO defends pharmacy middlemen, accuses drugmakers of ‘monopolistic’ practices
David Joyner, a longtime CVS executive, speaks during a Senate Health, Education, Labor and Pensions Committee hearing in Washington, D.C., on May 10, 2023. Al Drago | Bloomberg | Getty Images CVS Health CEO David Joyner on Wednesday defended controversial pharmacy middlemen like his company’s Caremark unit, which are widely accused of inflating prescription medication […]
Read More